Skip to main content
Official EU label nameGlossary entry 10958

GINSENOSIDE RD

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
2

Resolved substance identity

CAS:52705-93-8
EC:258-118-5
Ingredient index records:
GINSENOSIDE RD
Cosmetic functions: ANTIOXIDANT

\b-D-Glucopyranoside, (3.b\b.,12.\b)-20-(\b-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-\b- D-glucopyranosyl-

1 matched or reported name
GINSENOSIDE RD

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name GINSENOSIDE RD.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 52705-93-8
CAS 52705-93-8PubChem CID 11679800

Ginsenoside Rd

Ginsenoside Rd is a ginsenoside found in Panax ginseng and Panax japonicus var. major that is (20S)-ginsenoside Rg3 in which the hydroxy group at position 20 has been converted to its beta-D-glucopyranoside. It has a role as an anti-inflammatory drug, an immunosuppressive agent, a neuroprotective agent, an apoptosis inducer, a vulnerary and a plant metabolite. It is a beta-D-glucoside, a tetracyclic triterpenoid and a ginsenoside. It is functionally related to a (20S)-ginsenoside Rg3. — ChEBI

IUPAC name
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formula
C48H82O18
Molecular weight
947.2 g/mol
Exact mass
946.55011576 Da
XLogP3
2.4
Topological polar surface area
298.0 Ų
Hydrogen-bond donors
12
Hydrogen-bond acceptors
18
Covalent units
1
Defined stereocentres
25

Also known as

Gypenoside VIIIChikusetsusaponin fk7WB232T95AVCHEBI:679882-O-beta-D-Glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-D-glucopyranosidebeta-D-Glucopyranoside, (3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranosideRefChem:37442
16 more reported names
UNII-WB232T95AVGINSENOSIDE RD (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG)258-118-5ginsenoside-RdNSC-308876GS-RdG-Rd(20S)-ginsenoside Rd20(S)-ginsenoside RdGinsenoside Rd (Standard)(GS)-RdGypenoside VIII (Standard)HMS3885A14HY-N0043EINECS 258-118-5CCG-270588
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision